Jingwu Zhang Zang
Director/Board Member at HH&L ACQUISITION CO.
Net worth: 7 M $ as of 30/04/2024
Jingwu Zhang Zang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HH&L ACQUISITION CO. | Director/Board Member | 04/02/2021 | - |
| Independent Dir/Board Member | 04/02/2021 | - | |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Founder | 01/06/2016 | - |
| Chairman | 24/08/2016 | - | |
| Chief Executive Officer | 24/08/2016 | - |
Career history of Jingwu Zhang Zang
Former positions of Jingwu Zhang Zang
| Companies | Position | Start | End |
|---|---|---|---|
| I-MAB | Director/Board Member | 01/10/2019 | 01/03/2021 |
| Chief Executive Officer | 01/01/2022 | 30/09/2022 | |
| Chairman | 01/03/2021 | 10/02/2024 | |
| Founder | 30/06/2016 | 10/02/2024 | |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | President | 01/09/2013 | 01/04/2016 |
BioSciKin Co., Ltd.
 BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Chief Tech/Sci/R&D Officer | 01/09/2013 | 01/04/2016 |
| President | 01/09/2013 | 01/04/2016 | |
| Glaxosmithkline China Ltd. | Chief Tech/Sci/R&D Officer | 01/04/2007 | 01/06/2013 |
| Shanghai Jiao Tong University School of Medicine | Corporate Officer/Principal | 01/06/2002 | 01/04/2007 |
Institut Pasteur de Shanghai
 Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Director/Board Member | 01/10/2004 | 01/09/2006 |
| The Institute of Health Sciences | Director/Board Member | - | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jingwu Zhang Zang
| Shanghai Jiao Tong University | Doctorate Degree |
| Vrije Universiteit Brussel | Doctorate Degree |
Statistics
International
| China | 9 |
| United States | 4 |
| Belgium | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| I-MAB | Health Technology |
| Private companies | 7 |
|---|---|
| Opexa Pharmaceuticals, Inc. | Health Technology |
Institut Pasteur de Shanghai
Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Commercial Services |
| Glaxosmithkline China Ltd. | |
| The Institute of Health Sciences | |
BioSciKin Co., Ltd.
BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Health Technology |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
HH&L Acquisition Co.
 HH&L Acquisition Co. Financial ConglomeratesFinance HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 4, 2020 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Jingwu Zhang Zang
- Experience